Xeloda

Roche Laboratories is a leading healthcare company with a uniquely broad spectrum of innovative solutions. They have been active in the discovery, development, manufacturing and marketing of novel healthcare solutions, including Xeloda, their new drug used for treating breast and colorectal cancer patients.

The Xeloda Interactive Information Program was a highly targeted, two-wave Integrated eDetailing™ initiative designed to reach oncologists with highly-technical clinical information about the cancer drug Xeloda.